92 related articles for article (PubMed ID: 8512587)
1. Activation of the jun-D gene during treatment of human myeloid leukemia cells with 1-beta-D-arabinofuranosylcytosine.
Kharbanda S; Huberman E; Kufe D
Biochem Pharmacol; 1993 May; 45(10):2055-61. PubMed ID: 8512587
[TBL] [Abstract][Full Text] [Related]
2. Transcriptional and posttranscriptional regulation of H1 histone gene expression by 1-beta-D-arabinofuranosylcytosine.
Datta R; Kharbanda S; Kufe DW
Mol Pharmacol; 1992 Jan; 41(1):64-8. PubMed ID: 1732724
[TBL] [Abstract][Full Text] [Related]
3. Induction of c-jun expression in the myeloid leukemia cell line KG-1 by 1-beta-D-arabinofuranosylcytosine.
Henschler R; Brennscheidt U; Mertelsmann R; Herrmann F
Mol Pharmacol; 1991 Feb; 39(2):171-6. PubMed ID: 1996082
[TBL] [Abstract][Full Text] [Related]
4. Regulation of c-jun gene expression in HL-60 leukemia cells by 1-beta-D-arabinofuranosylcytosine. Potential involvement of a protein kinase C dependent mechanism.
Kharbanda S; Datta R; Kufe D
Biochemistry; 1991 Aug; 30(32):7947-52. PubMed ID: 1907849
[TBL] [Abstract][Full Text] [Related]
5. Transcriptional regulation of c-jun gene expression by arabinofuranosylcytosine in human myeloid leukemia cells.
Kharbanda SM; Sherman ML; Kufe DW
J Clin Invest; 1990 Nov; 86(5):1517-23. PubMed ID: 2122980
[TBL] [Abstract][Full Text] [Related]
6. Regulation of jun-B gene expression by 1-beta-D-arabinofuranosyl-cytosine in human myeloid leukemia cells.
Datta R; Kharbanda S; Kufe D
Mol Pharmacol; 1990 Oct; 38(4):435-9. PubMed ID: 2122229
[TBL] [Abstract][Full Text] [Related]
7. Activation of the transcription factor kappa B in human KG-1 myeloid leukemia cells treated with 1-beta-D-arabinofuranosylcytosine.
Brach MA; Kharbanda SM; Herrmann F; Kufe DW
Mol Pharmacol; 1992 Jan; 41(1):60-3. PubMed ID: 1732723
[TBL] [Abstract][Full Text] [Related]
8. 1-beta-D-arabinofuranosylcytosine activates serine/threonine protein kinases and c-jun gene expression in phorbol ester-resistant myeloid leukemia cells.
Kharbanda S; Emoto Y; Kisaki H; Saleem A; Kufe D
Mol Pharmacol; 1994 Jul; 46(1):67-72. PubMed ID: 8058058
[TBL] [Abstract][Full Text] [Related]
9. Activation of the AP-1 transcription factor by arabinofuranosylcytosine in myeloid leukemia cells.
Brach MA; Herrmann F; Kufe DW
Blood; 1992 Feb; 79(3):728-34. PubMed ID: 1310062
[TBL] [Abstract][Full Text] [Related]
10. Induction of c-fos gene expression by arabinofuranosylcytosine in human KG-1 leukemia cells.
Kharbanda S; Datta R; Kufe D
Cancer Commun; 1990; 2(12):409-14. PubMed ID: 2124813
[TBL] [Abstract][Full Text] [Related]
11. Activation of the early growth response 1 gene and nuclear pp90rsk in human myeloid leukemia cells by 1-(beta-D-arabinofuranosyl)cytosine.
Kharbanda S; Saleem A; Rubin E; Sukhatme V; Blenis J; Kufe D
Biochemistry; 1993 Sep; 32(35):9137-42. PubMed ID: 7690249
[TBL] [Abstract][Full Text] [Related]
12. Regulation of c-jun gene expression by cAMP in HL-60 myeloid leukemia cells.
Nakamura T; Datta R; Sherman ML; Kufe D
J Biol Chem; 1990 Dec; 265(35):22011-5. PubMed ID: 2174893
[TBL] [Abstract][Full Text] [Related]
13. Regulation of c-jun expression during induction of monocytic differentiation by okadaic acid.
Kharbanda S; Datta R; Rubin E; Nakamura T; Hass R; Kufe D
Cell Growth Differ; 1992 Jul; 3(7):391-9. PubMed ID: 1419903
[TBL] [Abstract][Full Text] [Related]
14. Regulation of jun-B expression by a cyclic AMP (cAMP)-dependent mechanism in human myeloid cells.
Datta R; Nakamura T; Sherman ML; Kufe D
Blood; 1991 Jul; 78(1):83-8. PubMed ID: 1648978
[TBL] [Abstract][Full Text] [Related]
15. Augmentation by aphidicolin of 1-beta-D-arabinofuranosylcytosine-induced c-jun and NF-kappa B activation in a human myeloid leukemia cell line: correlation with apoptosis.
Kuwakado K; Kubota M; Bessho R; Kataoka A; Usami I; Lin YW; Okuda A; Wakazono Y
Leuk Res; 1995 Sep; 19(9):645-50. PubMed ID: 7564475
[TBL] [Abstract][Full Text] [Related]
16. Effect of 1-beta-D-arabinofuranosylcytosine on apoptosis and differentiation in human monocytic leukemia cells (U937) expressing a c-Jun dominant-negative mutant protein (TAM67).
Grant S; Freemerman AJ; Birrer MJ; Martin HA; Turner AJ; Szabo E; Chelliah J; Jarvis WD
Cell Growth Differ; 1996 May; 7(5):603-13. PubMed ID: 8732670
[TBL] [Abstract][Full Text] [Related]
17. Activation of the c-jun protooncogene in human myeloid leukemia cells treated with etoposide.
Rubin E; Kharbanda S; Gunji H; Kufe D
Mol Pharmacol; 1991 Jun; 39(6):697-701. PubMed ID: 1904980
[TBL] [Abstract][Full Text] [Related]
18. Occupancy and composition of proteins bound to the AP-1 sites in the glucocorticoid receptor and c-jun promoters after glucocorticoid treatment and in different cell types.
Barrett TJ; Vedeckis WV
Recept Signal Transduct; 1996; 6(3-4):179-93. PubMed ID: 9259052
[TBL] [Abstract][Full Text] [Related]
19. Jun and Fos heterodimerize with ATFa, a member of the ATF/CREB family and modulate its transcriptional activity.
Chatton B; Bocco JL; Goetz J; Gaire M; Lutz Y; Kedinger C
Oncogene; 1994 Feb; 9(2):375-85. PubMed ID: 8290251
[TBL] [Abstract][Full Text] [Related]
20. 1-beta-D-arabinofuranosylcytosine activates tyrosine phosphorylation of p34cdc2 and its association with the Src-like p56/p53lyn kinase in human myeloid leukemia cells.
Yuan ZM; Kharbanda S; Kufe D
Biochemistry; 1995 Jan; 34(3):1058-63. PubMed ID: 7530044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]